News
A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...
The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback